(Q36536651)

14 August 2017

1 reference

title

Immunology of canine leishmaniasis (English)

1 reference

14 August 2017

1 reference

Barbiéri CL

1

1 reference

14 August 2017

publication date

1 July 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

28

1 reference

14 August 2017

issue

7

1 reference

14 August 2017

page(s)

329-337

1 reference

The strange case of Leishmania chagasi

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

A retrospective clinical study of canine leishmaniasis in 150 dogs naturally infected by Leishmania infantum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Early suppression of lymphoproliferative response in dogs with natural infection by Leishmania infantum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Detection of canine cytokine gene expression by reverse transcription-polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Cytokine expression during the outcome of canine experimental infection by Leishmania infantum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Infection of a canine macrophage cell line with leishmania infantum: determination of nitric oxide production and anti-leishmanial activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Recombinant cysteine proteinase from Leishmania (Leishmania) chagasi implicated in human and dog T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Cell mediated immunity and specific IgG1 and IgG2 antibody response in natural and experimental canine leishmaniosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

IgG subclass responses in a longitudinal study of canine visceral leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

DNA vaccination: the answer to stable, protective T-cell memory?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Mapping and sequencing of the canine NRAMP1 gene and identification of mutations in leishmaniasis-susceptible dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Immunization of dogs with a Leishmania infantum-derived vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (São Gonçalo do Amaranto, RN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Vaccination of mice against Leishmania mexicana amazonensis with microsomal fraction associated with BCG

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Expression of cysteine proteinase type I and II of Leishmania infantum and their recognition by sera during canine and human visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Humoral and cellular immune responses against Type I cysteine proteinase of Leishmania infantum are higher in asymptomatic than symptomatic dogs selected from a naturally infected population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Down-regulation of MHC class II receptors of DH82 cells, following infection with Ehrlichia canis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Taxonomy of Leishmania. Use of isoenzymes. Suggestions for a new classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Infectivity of dogs naturally infected with Leishmania infantum to colonized Phlebotomus perniciosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Immunoglobulin G and E responses in various stages of canine leishmaniosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Use of a leishmanin skin test in the detection of canine Leishmania-specific cellular immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

The Ibizian hound presents a predominantly cellular immune response against natural Leishmania infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Humoral and cell-mediated immunity in natural and experimental canine leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Nitric oxide production by macrophages of dogs vaccinated with killed Leishmania infantum promastigotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Tissue cytokine responses in canine visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Analysis of the humoral immune response against total and recombinant antigens of Leishmania infantum: correlation with disease progression in canine experimental leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Antileishmanial antibody profile in dogs naturally infected with Leishmania chagasi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S�o Gon�alo do Amarante, RN)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00840.X

10.1111/J.1365-3024.2006.00840.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference